139 related articles for article (PubMed ID: 33937087)
1. Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells
Booth L; West C; Von Hoff D; Dent P
Front Oncol; 2021; 11():677725. PubMed ID: 33937087
[TBL] [Abstract][Full Text] [Related]
2. GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling.
Booth L; West C; Hoff DV; Dent P
Front Oncol; 2020; 10():1331. PubMed ID: 32983965
[TBL] [Abstract][Full Text] [Related]
3. GZ17-6.02 Interacts With [MEK1/2 and B-RAF Inhibitors] to Kill Melanoma Cells.
Booth L; West C; Von Hoff D; Kirkwood JM; Dent P
Front Oncol; 2021; 11():656453. PubMed ID: 33898322
[TBL] [Abstract][Full Text] [Related]
4. GZ17-6.02 initiates DNA damage causing autophagosome-dependent HDAC degradation resulting in enhanced anti-PD1 checkpoint inhibitory antibody efficacy.
Booth L; Roberts JL; West C; Von Hoff D; Dent P
J Cell Physiol; 2020 Nov; 235(11):8098-8113. PubMed ID: 31951027
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis.
Liu X; Zhou Z; Wang Y; Zhu K; Deng W; Li Y; Zhou X; Chen L; Li Y; Xie A; Zeng T; Wang G; Fu B
Front Oncol; 2020; 10():1735. PubMed ID: 33014857
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.
Li Z; Chen C; Chen L; Hu D; Yang X; Zhuo W; Chen Y; Yang J; Zhou Y; Mao M; Zhang X; Xu L; Ju S; Shen J; Wang Q; Dong M; Xie S; Wei Q; Jia Y; Zhou J; Wang L
Front Oncol; 2022; 12():880458. PubMed ID: 35356217
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.
Li B; Zhao X; Zhang L; Cheng W
Front Oncol; 2021; 11():687841. PubMed ID: 34150656
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group.
Racanelli D; Brenca M; Baldazzi D; Goeman F; Casini B; De Angelis B; Guercio M; Milano GM; Tamborini E; Busico A; Dagrada G; Garofalo C; Caruso C; Brunello A; Pignochino Y; Berrino E; Grignani G; Scotlandi K; Parra A; Hattinger CM; Ibrahim T; Mercatali L; De Vita A; Carriero MV; Pallocca M; Loria R; Covello R; Sbaraglia M; Dei Tos AP; Falcioni R; Maestro R
Front Oncol; 2020; 10():944. PubMed ID: 32656080
[TBL] [Abstract][Full Text] [Related]
9. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells.
Fulda S; Strauss G; Meyer E; Debatin KM
Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach.
Tai YK; Chan KKW; Fong CHH; Ramanan S; Yap JLY; Yin JN; Yip YS; Tan WR; Koh APF; Tan NS; Chan CW; Huang RYJ; Li JZ; Fröhlich J; Franco-Obregón A
Front Oncol; 2022; 12():892408. PubMed ID: 35515135
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation.
Chatterjee R; Shukla A; Chakrabarti K; Chatterji U
Front Oncol; 2024; 14():1393626. PubMed ID: 38549942
[TBL] [Abstract][Full Text] [Related]
12. Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Vishwakarma V; New J; Kumar D; Snyder V; Arnold L; Nissen E; Hu Q; Cheng N; Miller D; Thomas AR; Shnayder Y; Kakarala K; Tsue TT; Girod DA; Thomas SM
Sci Rep; 2018 Aug; 8(1):12163. PubMed ID: 30111862
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines.
Yuan B; Xu K; Shimada R; Li J; Hayashi H; Okazaki M; Takagi N
Front Oncol; 2021; 11():778834. PubMed ID: 34692557
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.
Pan H; Pan J; Song S; Ji L; Lv H; Yang Z
Front Oncol; 2021; 11():670041. PubMed ID: 33898326
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Decreased DUSP26 Expression Promotes Malignant Behavior in Glioblastoma Cells
Chen J; Zeng Y; Wu R; Xuan Y; Jiang M; Teng H
Front Oncol; 2021; 11():676647. PubMed ID: 33928040
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma.
Nath LR; Swetha M; Vijayakurup V; Thangarasu AK; Haritha NH; Shabna A; Aiswarya SU; Rayginia TP; Keerthana CK; Kalimuthu K; Sundaram S; Lankalapalli RS; Pillai S; Towner R; Isakov N; Anto RJ
Front Oncol; 2022; 12():991401. PubMed ID: 36091117
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Antiproliferative effects of the natural oxadiazine Nocuolin A are associated with impairment of mitochondrial oxidative phosphorylation.
Sousa ML; Preto M; Vasconcelos V; Linder S; Urbatzka R
Front Oncol; 2023; 13():1228436. PubMed ID: 37333819
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Combinatorial Strategies to Target Molecularand Signaling Pathways to Disarm Cancer Stem Cells.
Catara G; Colanzi A; Spano D
Front Oncol; 2021; 11():749040. PubMed ID: 34485166
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: RAB42 promotes glioma pathogenesis
Liu B; Su Q; Xiao B; Zheng G; Zhang L; Yin J; Wang L; Che F; Heng X
Front Oncol; 2022; 12():1034167. PubMed ID: 36276111
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Co-treatment of chloroquine and trametinib inhibits melanoma cell proliferation and decreases immune cell infiltration.
Degan S; May BL; Jin YJ; Ben Hammouda M; Sun H; Zhang G; Wang Y; Erdmann D; Warren W; Zhang JY
Front Oncol; 2024; 14():1418213. PubMed ID: 38746676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
